Integrating nanomedicine into clinical radiotherapy regimens

Allison N. DuRoss, Megan J. Neufeld, Shushan Rana, Charles R. Thomas, Conroy Sun

Research output: Contribution to journalReview articlepeer-review

21 Scopus citations


While the advancement of clinical radiotherapy was driven by technological innovations throughout the 20th century, continued improvement relies on rational combination therapies derived from biological insights. In this review, we highlight the importance of combination radiotherapy in the era of precision medicine. Specifically, we survey and summarize the areas of research where improved understanding in cancer biology will propel the field of radiotherapy forward by allowing integration of novel nanotechnology-based treatments.

Original languageEnglish (US)
Pages (from-to)35-56
Number of pages22
JournalAdvanced Drug Delivery Reviews
StatePublished - Apr 2019


  • Cancer
  • Chemoradiotherapy
  • Dosing
  • Drug delivery
  • Multimodal therapy
  • Nanoparticles
  • Radiation therapy

ASJC Scopus subject areas

  • Pharmaceutical Science


Dive into the research topics of 'Integrating nanomedicine into clinical radiotherapy regimens'. Together they form a unique fingerprint.

Cite this